Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leptin Replacement in Leptin-Deficient Children
NCT00659828Phase 2Completed
- Sponsor
- University of Miami
- Start
- Jun 2005
- Primary completion
- Apr 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of metreleptin in congenital leptin deficiency (CLD), sponsored by University of Miami. Started Jun 2005; status: completed.
02
Drugs
metreleptin
03
Conditions
congenital leptin deficiency (CLD)
Beyond the preview
Go deeper on NCT00659828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00659828.